News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
FREYMAN THOMAS C
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 05/09/2023 |
4
| FREYMAN THOMAS C (Director) has filed a Form 4 on AbbVie Inc.|
Txns:
| Granted 1,450 shares
@ $0 |
|
| 11/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/04/2022 |
4
| FREYMAN THOMAS C (Director) has filed a Form 4 on HANGER, INC.|
Txns:
| Disposed/sold 43,561 shares
@ $18.75, valued at
$816.8k
|
|
| 06/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/09/2022 |
4
| FREYMAN THOMAS C (Director) has filed a Form 4 on AbbVie Inc.|
Txns:
| Granted 1,421 shares
@ $0 |
|
| 02/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/27/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/11/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/07/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/22/2020 |
4/A
| FREYMAN THOMAS C (Director) has filed a Form 4 on AbbVie Inc.|
Txns:
| Granted 2,583 shares
@ $0
Granted 2,333 shares
@ $0 |
|
| 05/22/2020 |
3/A
| FREYMAN THOMAS C (Director) has filed a Form 3/A on AbbVie Inc. |
| 05/21/2020 |
4
| FREYMAN THOMAS C (Director) has filed a Form 4 on HANGER, INC.|
Txns:
| Granted 8,178 shares
@ $0 |
|
| 05/12/2020 |
4
| FREYMAN THOMAS C (Director) has filed a Form 4 on AbbVie Inc.|
Txns:
| Granted 2,583 shares
@ $0
Granted 2,333 shares
@ $0 |
|
| 05/12/2020 |
3/A
| FREYMAN THOMAS C (Director) has filed a Form 3/A on AbbVie Inc. |
| 05/12/2020 |
3
| FREYMAN THOMAS C (Director) has filed a Form 3 on AbbVie Inc. |
| 05/11/2020 |
4
| FREYMAN THOMAS C (Director) has filed a Form 4 on Allergan plc|
Txns:
| Disposed/sold 2,983 shares
@ $0 |
|
| 05/04/2020 |
4
| FREYMAN THOMAS C (Director) has filed a Form 4 on Allergan plc|
Txns:
| Paid exercise price by delivering 2,064 shares
@ $189.74, valued at
$391.6k
|
|
| 02/06/2020 |
4
| FREYMAN THOMAS C (Director) has filed a Form 4 on TENNECO INC|
Txns:
| Granted 12,208 shares
@ $0 |
|
| 05/24/2019 |
4
| FREYMAN THOMAS C (Director) has filed a Form 4 on HANGER, INC.|
Txns:
| Granted 6,969 shares
@ $0 |
|
| 05/02/2019 |
4
| FREYMAN THOMAS C (Director) has filed a Form 4 on Allergan plc|
Txns:
| Paid exercise price by delivering 748 shares
@ $147, valued at
$110k
Granted 2,064 shares
@ $145.33, valued at
$300k
|
|
| 02/07/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/04/2018 |
4
| FREYMAN THOMAS C (Director) has filed a Form 4 on Allergan plc|
Txns:
| Bought 1,100 shares
@ $190.69, valued at
$209.8k
|
|
| 08/10/2018 |
4
| FREYMAN THOMAS C (Director) has filed a Form 4 on TENNECO INC|
Txns:
| Bought 5,000 shares
@ $44.49, valued at
$222.5k
|
|
| 06/15/2018 |
4
| FREYMAN THOMAS C (Director) has filed a Form 4 on Allergan plc|
Txns:
| Granted 1,558 shares
@ $170.23, valued at
$265.2k
|
|
| 06/15/2018 |
3
| FREYMAN THOMAS C (Director) has filed a Form 3 on Allergan plc |
| 05/17/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/09/2018 |
4
| FREYMAN THOMAS C (Director) has filed a Form 4 on TENNECO INC|
Txns:
| Granted 2,180 shares
@ $0 |
|
| 11/17/2017 |
4
| FREYMAN THOMAS C (Director) has filed a Form 4 on HANGER, INC.|
Txns:
| Granted 5,347 shares
@ $0 |
|
| 11/17/2017 |
3
| FREYMAN THOMAS C (Director) has filed a Form 3 on HANGER, INC. |
| 02/03/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 08/04/2016 |
4
| FREYMAN THOMAS C (Director) has filed a Form 4 on TENNECO INC|
Txns:
| Acquired 2,757 shares
@ $0
Disposed of 2,757 shares
@ $0 |
|
| 07/29/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/02/2016 |
4
| FREYMAN THOMAS C (Executive Vice President) has filed a Form 4 on ABBOTT LABORATORIES|
Txns:
| Paid exercise price by delivering 19,908 shares
@ $39.52, valued at
$786.8k
|
|
|
|
|